Diethanolamine (DEA), Monoethanolamine (MEA), and Triethanolmine (TEA) are hormone-disrupting chemicals known to form nitrates and nitrosamines, often in conjunction with other chemicals present in a product, e.g. Cocamide DEA, or Lauramide DEA. They are almost always in products that foam: bubble bath, body wash, shampoo, soap, facial cleanser.
On the US TV show "CBS This Morning", Roberta Baskin said that "It [DEA] is in hundreds of cosmetic products....but it does something more than make soap bubbles. A Federal government study says that DEA and DEA-based detergents have been shown to greatly increase the risk of cancer, especially liver and kidney cancer…."
John Bailey, head of the cosmetic division for the FDA, says that the new study is especially important since "the risk equation changes significantly for children." Tests at the University of Bologna in Italy found TEA to be the most frequent sensitiser used in cosmetics, gels, shampoos, creams, lotions, etc.
U. S. Food and Drug Administration
Centre for Food Safety and Applied Nutrition
Office of Cosmetics Fact Sheet
December 9, 1999
The National Toxicology Program (NTP) completed a study in 1998 that found an association between the topical application of diethanolamine (DEA) and certain DEA-related ingredients and cancer in laboratory animals. For the DEA-related ingredients, the NTP study suggests that the carcinogenic response is linked to possible residual levels of DEA. The NTP study did not establish a link between DEA and the risk of cancer in humans.
Although DEA itself is used in very few cosmetics, DEA-related ingredients are widely used in a variety of cosmetic products. These ingredients function as emulsifiers or foaming agents and generally are used at levels of 1 to 5% of a product's formulation.
FDA takes the results of the NTP study very seriously and has made the assessment of public health risk one of the highest priorities for the cosmetics program. To determine whether or not the NTP findings suggest a risk to human health, FDA is in the process of carefully evaluating the studies and test data to determine the real risk, if any, to consumers. This evaluation includes laboratory studies to measure the degree to which DEA penetrates human skin and the amount of DEA found in commercial products.